ASTRIA THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.64 USD | -1.63% |
|
-13.15% | +25.52% |
Chart calendar Astria Therapeutics, Inc.
7f5d23.5ZBeERw4NOLZgyZYA1v6mSn6Alqn3h2I3DLgSQiKyXI.tOAJZHZKZ4q_yWJoNgmAq2qNYyrjlCi8u3uQOGLCmDWmowxeawtMqprPUQ~41952dc95aa8b5e7cf7373505056845c
Upcoming events on Astria Therapeutics, Inc.
Past events on Astria Therapeutics, Inc.
| 2024-03-25 08:30 am | ALPHA-STAR Phase 1b/2 Trial Results Call |
| 2024-03-04 04:10 pm | Q4 2023 Earnings Release |
| 2024-02-23 03:15 pm | American Academy of Allergy, Asthma, & Immunology Meeting - Poster Number: 032 |
| 2024-02-13 09:20 am | Oppenheimer Healthcare Life Sciences Conference |
| 2023-12-02 10:00 pm | World Allergy Congress |
| 2023-11-30 08:45 am | Evercore ISI HealthCONx Conference |
| 2023-11-15 05:30 am | Jefferies London Healthcare Conference |
| 2023-11-13 08:30 am | Q3 2023 Earnings Call |
| 2023-11-13 08:00 am | Q3 2023 Earnings Release |
| 2023-11-11 03:35 pm | American College of Allergy Asthma & Immunology Scientific Meeting |
| 2023-10-12 08:30 am | Business Update Call |
| 2023-09-12 | Morgan Stanley Global Healthcare Conference |
| 2023-09-12 10:00 am | H.C. Wainwright Global Investment Conference |
| 2023-09-01 01:30 am | HAEi Regional EMEA Conference |
| 2023-08-07 | Wedbush PacGrow Healthcare Conference |
| 2023-08-07 04:10 pm | Q2 2023 Earnings Release |
| 2023-07-21 07:45 am | US Hereditary Angioedema Association National Summit |
| 2023-06-09 07:15 am | European Academy of Allergy, Asthma, and Immunology Meeting - Dr. Marcus Maurer, M.D |
| 2023-06-09 07:15 am | European Academy of Allergy, Asthma, and Immunology Meeting - Dr. William Lumry, M.D |
| 2023-06-09 06:00 am | European Academy of Allergy, Asthma, and Immunology Meeting - Nikolaos Biris, Ph.D |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | -195 -194 -0.45% | -53,5 -51,9 -3.09% | -83,0 -69,9 -18.78% | -82,7 |
|
EBIT Million USD | Released Forecast Spread | -27,1 -27,7 2.26% | -37,4 -39,6 5.47% | -195 -194 -0.71% | -53,5 -52,9 -1.06% | -83,0 -78,8 -5.31% | -89,1 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -26,3 -26,9 2.15% | -37,3 -39,5 5.48% | -195 -200 2.47% | -51,8 -52,4 0.99% | -72,9 -69,0 -5.69% | -79,6 |
|
Net income Million USD | Released Forecast Spread | -26,3 -26,9 2.15% | -37,3 -38,2 2.34% | -195 -208 6.47% | -51,8 -52,1 0.58% | -72,9 -71,0 -2.71% | -79,6 |
|
EPS USD | Released Forecast Spread | -14,1 -14,5 2.69% | -12,2 -11,0 -10.93% | -24,6 -16,5 -49.4% | -3,55 -3,51 -1.19% | -2,42 -2,23 -8.45% | -1,55 |
| Announcement Date | 10/03/20 | 11/03/21 | 10/03/22 | 22/03/23 | 04/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -9,51 -8,60 -10.56% | -15,4 -8,10 -89.85% | -11,4 -15,6 26.61% | -12,4 -12,2 -1.52% | -14,3 -12,7 -12.52% | -13,5 -14,6 7.58% | -15,1 -15,7 3.81% | -20,2 -16,6 -21.9% | -34,2 -21,1 -62.08% | -19,3 | -20,3 | -21,4 | -21,7 | |
|
EBIT Million USD | Released Forecast Spread | -9,51 -8,13 -16.91% | -15,4 -9,21 -66.91% | -11,4 -13,1 12.47% | -12,4 -12,6 1.42% | -14,3 -14,0 -2.16% | -13,5 -14,2 5.27% | -15,1 -15,2 0.47% | -20,2 -16,9 -19.91% | -34,2 -32,2 -6.06% | -20,1 | -21,6 | -23,6 | -25,3 | -27,8 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -9,49 -8,06 -17.77% | -15,3 -8,81 -73.86% | -11,3 -13,7 17.86% | -12,0 -12,6 4.44% | -13,3 -13,8 3.73% | -11,2 -14,0 20.21% | -12,6 -13,6 7.37% | -17,7 -15,0 -18.2% | -31,4 -27,5 -14.18% | -17,7 | -19,0 | -20,9 | -22,1 | -25,1 |
|
Net income Million USD | Released Forecast Spread | -9,49 -8,30 -14.41% | -15,3 -8,74 -75.35% | -11,3 -13,7 17.86% | -12,0 -12,5 4.05% | -13,3 -13,6 2.19% | -11,2 -14,2 20.97% | -12,6 -13,9 9.31% | -17,7 -15,4 -15.03% | -31,4 -29,5 -6.47% | -17,7 | -19,0 | -20,9 | -22,1 | -25,1 |
|
EPS USD | Released Forecast Spread | -0,73 -0,62 -17.74% | -1,18 -0,73 -62.09% | -0,86 -1,02 15.27% | -0,87 -0,92 5.23% | -0,72 -0,71 -1.17% | -0,40 -0,55 27.49% | -0,45 -0,49 7.53% | -0,63 -0,49 -29.45% | -0,94 -0,78 -20.51% | -0,36 | -0,36 | -0,40 | -0,42 | -0,44 |
| Announcement Date | 10/03/22 | 12/05/22 | 09/08/22 | 10/11/22 | 22/03/23 | 11/05/23 | 07/08/23 | 13/11/23 | 04/03/24 | - | - | - | - | - |
More events
Past sector events for Astria Therapeutics, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ATXS Stock
- Calendar Astria Therapeutics, Inc.
